Article Text

Download PDFPDF

B76 Saphenous nerve block reduces length of stay after epiphysiodesis of the knee – a triple blind randomized superiority trial
Free
  1. CA Abusaris1,
  2. L Van Rozen2,
  3. M Heeg2 and
  4. A Ott3
  1. 1Wilhelmina Hospital Assen/Department of Anesthesiology, Assen, Netherlands
  2. 2Wilhelmina Hospital Assen/Department of Orthopedic Surgery, Assen, Netherlands
  3. 3Medical diagnostics and advice Certe/Department of Microbiology, Groningen, Netherlands

Abstract

Background and Aims The aim of this triple blind randomized controlled trial was to compare a bilateral single shot saphenous nerve block to placebo in postoperative pain management after percutan epiphysiodesis of the genual growths plates.

Methods We included 44 patients ASA 1–2, aged 12–18 years; 21 patients received single shot nerve blocks with 10 ml ropivacaine 0.5% per leg; 23 patients received their nerve blocks with 10 ml NaCl 0.9% per leg. General anesthesia and postoperative analgesics were standardized. The main endpoint was length of stay (LOS). We further investigated intra- and postoperative opioid consumption, NRS pain scores, time in the post anesthetic care unit, time to walk (with crutches) and overall patient satisfaction. The Regional Ethics Committee Groningen, The Netherlands gave approval.

Results We observed a median LOS of 41 hours in the intervention group versus 48 hours in the placebo group (p= 0.08), which was not statistically significant but clinically relevant in the sense of discharge management and efficiency. We could show overall low painscores (NRS 0–1.6) with significant difference on the first postoperative night (NRS 1.1 vs 0.5) in favour of the intervention.

Conclusions We could not show statistical significant superiority of the saphenous nerve block. The intervention did support the concept of efficient multimodal pain managment on the ward and didn’t show drawbacks like delayed ambulation.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.